Back
Virtus Equity & Convertible Income Fund Vs. Moderna, Inc. Industry Stock Comparison
Sell
48
NIE
Virtus Equity & Convertible Income Fund
Last Price:
$23.56
Seasonality Move:
2.29%
Sell
33
MRNA
Moderna, Inc.
Last Price:
$49.23
Seasonality Move:
20.07%
Sell
48
Virtus Equity & Convertible Income Fund (NIE)
is a Sell
Is Virtus Equity & Convertible Income Fund a Buy, Sell or Hold?
-
The current Virtus Equity & Convertible Income Fund [NIE] share price is $23.57. The Score for NIE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
NIE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Moderna, Inc. (MRNA)
is a Sell
Is Moderna, Inc. a Buy, Sell or Hold?
-
The current Moderna, Inc. [MRNA] share price is $49.20. The Score for MRNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
MRNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NIE Stock Price Chart
What is Virtus Equity & Convertible Income Fund's stock price today?
-
The Virtus Equity & Convertible Income Fund share price today is $23.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NIE is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRNA Stock Price Chart
What is Moderna, Inc.'s stock price today?
-
The Moderna, Inc. share price today is $49.20The current trend is moderately bearish and MRNA is experiencing slight selling pressure.
NIE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 40.45 | Sell |
| Chaikin Money Flow: | 73058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.39 - 24.93) | Sell |
| Bollinger Bands (100): | (24.34 - 25.72) | Sell |
MRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 46.04 | Sell |
| Chaikin Money Flow: | -422045 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 54.78) | Sell |
| Bollinger Bands (100): | (28.82 - 50.48) | Buy |
NIE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.34 | Buy |
| 20-day SMA: | 23.87 | Sell |
| 50-day SMA: | 24.8 | Sell |
| 200-day SMA: | 24.82 | Sell |
| 8-day EMA: | 23.46 | Buy |
| 20-day EMA: | 23.85 | Sell |
| 50-day EMA: | 24.48 | Sell |
| 200-day EMA: | 24.62 | Sell |
MRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.78 | Sell |
| 20-day SMA: | 52.31 | Sell |
| 50-day SMA: | 49.09 | Buy |
| 200-day SMA: | 33.54 | Buy |
| 8-day EMA: | 50.49 | Sell |
| 20-day EMA: | 51.09 | Sell |
| 50-day EMA: | 48.04 | Buy |
| 200-day EMA: | 39.22 | Buy |
Virtus Equity & Convertible Income Fund Earnings Growth & NIE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Moderna, Inc. Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $1.29 per share, an increase this year of $0.93 per share, and an increase next year of $2.33 per share.
Virtus Equity & Convertible Income Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Moderna, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||